Disease | hepatitis |
Phenotype | C0022661|end stage renal disease |
Sentences | 1 |
PubMedID- 26095179 | Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of hepatitis c in patients with end stage renal disease. |
Page: 1